Pfizer Expands its Collaboration with Flatiron Health to Integrate the Use of Real-World Evidence in Oncology
Shots:
- Pfizer will utilize Flatiron’s de-identified- real-world datasets and analytical expertise to inform development strategies for clinical development projects across multiple tumor types and will jointly explore other ways to drive clinical development innovation with real-world data
- The collaboration focuses on integrating real-world data insights into clinical development across Pfizer’s oncology portfolio and will identify the future areas of collaboration which will evolve real-world evidence
- The collaboration includes datasets from multiple tumor types including NSCLC & CRC and will explore the implications of real-world data with the scientific and healthcare communities to utilize it in making a regulatory decision
Ref: Pfizer | Image: Stat
Click here to read full press release/ article
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com